Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Addus HomeCare Corporation - Common Stock (NQ:ADUS)

112.58 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Addus HomeCare Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Senior Health, Home Health & Hospice Stocks Q4 Recap: Benchmarking The Pennant Group (NASDAQ:PNTG)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at The Pennant Group (NASDAQ:PNTG) and its peers. 
Via StockStory
Topics Economy
What Analysts Are Saying About Addus HomeCare Stock
 
Via Benzinga
Q4 Rundown: Addus HomeCare (NASDAQ:ADUS) Vs Other Senior Health, Home Health & Hospice Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at senior health, home health & hospice... 
Via StockStory
Topics Economy
Analyst Expectations For Addus HomeCare's Future
 
Via Benzinga
Deep Dive Into Addus HomeCare Stock: Analyst Perspectives (6 Ratings)
 
Via Benzinga
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q4 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest Of The Pack
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers. 
Via StockStory
Topics Economy
3 Reasons ADUS is Risky and 1 Stock to Buy Instead
Addus HomeCare has gotten torched over the last six months - since September 2024, its stock price has dropped 26.9% to $95.71 per share. This may have investors wondering how to approach the... 
Via StockStory
Senior Health, Home Health & Hospice Stocks Q4 Earnings: Option Care Health (NASDAQ:OPCH) Best of the Bunch
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers. 
Via StockStory
Topics Economy
Is NASDAQ:ADUS a Suitable Choice for Quality Investing?
Why Quality Investors May Find ADDUS HOMECARE CORP (NASDAQ:ADUS) Attractive. 
Via Chartmill
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing?
Should Quality-Oriented Investors Explore ADDUS HOMECARE CORP (NASDAQ:ADUS)? 
Via Chartmill
Assessing Addus HomeCare: Insights From 9 Financial Analysts
 
Via Benzinga
The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Experts
 
Via Benzinga
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Pack
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group... 
Via StockStory
BrightSpring Health Services (BTSG) Q4 Earnings: What To Expect
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
What To Expect From Chemed’s (CHE) Q4 Earnings
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what to expect. 
Via StockStory
Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect
Alternate site health provider Option Care Health (NASDAQ:OPCH) will be reporting earnings tomorrow before market open. Here’s what to look for. 
Via StockStory
Demystifying Addus HomeCare: Insights From 8 Analyst Reviews
 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
 
Via Benzinga
Addus HomeCare (NASDAQ:ADUS) Surprises With Q4 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of... 
Via StockStory
Earnings Scheduled For February 24, 2025
 
Via Benzinga
Addus HomeCare (ADUS) To Report Earnings Tomorrow: Here Is What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings tomorrow after market hours. Here’s what to look for. 
Via StockStory
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers. 
Via StockStory
Topics Economy
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers. 
Via StockStory
Topics Economy
Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice... 
Via StockStory
Topics Economy
Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare... 
Via StockStory
Topics Economy
DaVita Stock Sees Improved Relative Strength Rating
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72. 
Via Investor's Business Daily
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth. 
Via Benzinga
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.